Genetic and immunologic characteristics of colorectal cancer patients with KRAS mutations and predictive significance of tumor immune microenvironment in adjuvant chemotherapy
返回论文页
Short communication|更新时间:2024-02-04
|
Genetic and immunologic characteristics of colorectal cancer patients with KRAS mutations and predictive significance of tumor immune microenvironment in adjuvant chemotherapy
Genes & DiseasesVol. 11, Issue 3, (2024)
作者机构:
1. Department of General Surgery, The First People's Hospital of Yunnan Province,Yunnan,Kunming,China,650000
2. Department of Oncology, The First Affiliated Hospital of Kunming Medical University,Yunnan,Kunming,China,650032
3. Department of General Surgery, The Affiliated Hospital of Yunnan University,Yunnan,China,650011
4. Zhaotong Health Vocational College,Yunnan,Zhaotong,China,657000
5. The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Center),Yunnan,Kunming,China,650021
6. School of Nursing, Yunnan University of Chinese Medicine,Yunnan,Kunming,China,650022
7. Gastrointestinal and Hernia Surgery, The First Affiliated Hospital of Kunming Medical University,Yunnan,Kunming,China,650032
8. Medical Department, 3D Medicines Inc.,Shanghai,China,201114
Zhengqi Wen, Wenliang Li, Chengmin Shi, et al. Genetic and immunologic characteristics of colorectal cancer patients with KRAS mutations and predictive significance of tumor immune microenvironment in adjuvant chemotherapy. [J]. Genes & Diseases 11(3).(2024)
DOI:
Zhengqi Wen, Wenliang Li, Chengmin Shi, et al. Genetic and immunologic characteristics of colorectal cancer patients with KRAS mutations and predictive significance of tumor immune microenvironment in adjuvant chemotherapy. [J]. Genes & Diseases 11(3).(2024) DOI: 10.1016/j.gendis.2023.05.002.
Genetic and immunologic characteristics of colorectal cancer patients with KRAS mutations and predictive significance of tumor immune microenvironment in adjuvant chemotherapy